Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ART 101 - Archeus Technologies

Next Previous
Drug Profile

ART 101 - Archeus Technologies

Alternative Names: ART-101 - Archeus Technologies

Latest Information Update: 04 Jul 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Wisconsin Alumni Research Foundation
  • Developer Archeus Technologies; Wisconsin Alumni Research Foundation
  • Class Antineoplastics; Diagnostic agents; Radiopharmaceutical diagnostics; Radiopharmaceuticals; Small molecules
  • Mechanism of Action Ionising radiation emitters; Positron-emission tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Prostate cancer

Most Recent Events

  • 20 Jun 2025 Preclinical trials in Prostate cancer (Diagnosis) in USA (unspecified route)
  • 20 Jun 2025 US FDA approves IND application for ART 101 for phase-I trial in Prostate cancer (Diagnosis and Treatment)
  • 28 May 2025 Archeus Technologies and Wisconsin Alumni Research Foundation of the University of Wisconsin–Madison (UW) enteres into a collaboration agreement to develop ART 101 for Prostate cancer

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top